116 related articles for article (PubMed ID: 1888817)
21. A controlled study of 20 mg famotidine nocte vs. 150 mg ranitidine nocte for the prevention of duodenal ulcer relapse.
Bianchi Porro G; Lazzaroni M; Barbara L; Corinaldesi R; Blasi A; Mangiameli A; Capurso L; Koch M; Cheli R; Bovero E
Aliment Pharmacol Ther; 1991 Apr; 5(2):181-9. PubMed ID: 1888818
[TBL] [Abstract][Full Text] [Related]
22. [Famotidine versus placebo in prevention of the recurrence of duodenal ulcer disease. A multicenter study in Germany, Austria and Italy].
Baglioni A; Barbara L; Bianchi-Porro G; Blasi A; Canelli B; Cheli R; Dal Monte R; Dammann HG; Francavilla A; Hentschel E
Z Gastroenterol; 1985 Dec; 23(12):665-9. PubMed ID: 2868581
[TBL] [Abstract][Full Text] [Related]
23. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
Ogawa N
Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
[TBL] [Abstract][Full Text] [Related]
24. The effects of intermittent and continuous intravenous infusion of famotidine on gastric acidity in patients with peptic ulcers.
Watanabe Y; Tsumura H; Sasaki H; Morimoto T
Clin Ther; 1990; 12(6):534-46. PubMed ID: 2289221
[TBL] [Abstract][Full Text] [Related]
25. Famotidine (MK-208) in the treatment of gastric ulcer. Results of a multicenter double-blind controlled study.
Paoluzi P; Torsoli A; Bianchi Porro G; Lazzaroni M; Barbara L; Corinaldesi R; Blasi A; Mangiameli A; Carratelli L; Cheli R
Digestion; 1985; 32 Suppl 1():38-44. PubMed ID: 2866135
[TBL] [Abstract][Full Text] [Related]
26. Randomized, double-blind comparison of famotidine with ranitidine in treatment of acute, benign gastric ulcer disease. Community-based study coupled with a patient registry.
Brazer SR; Tyor MP; Pancotto FS; Brice RS; Garbutt JT; Wildermann NM; Harrell FE; Pryor DB; Liss CL; Root JK
Dig Dis Sci; 1989 Jul; 34(7):1047-52. PubMed ID: 2568247
[TBL] [Abstract][Full Text] [Related]
27. Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial.
Hsu PI; Wu DC; Tsay FW; Cheng JS; Liu CP; Lai KH; Chen WC; Wang HM; Tsai TJ; Tsai KW; Kao SS
Am J Gastroenterol; 2017 Feb; 112(2):282-289. PubMed ID: 27922030
[TBL] [Abstract][Full Text] [Related]
28. Randomized comparison of gastric pH control with intermittent and continuous intravenous infusion of famotidine in ICU patients.
Heiselman DE; Hulisz DT; Fricker R; Bredle DL; Black LD
Am J Gastroenterol; 1995 Feb; 90(2):277-9. PubMed ID: 7847300
[TBL] [Abstract][Full Text] [Related]
29. Acid suppression by famotidine 20 mg twice daily or 40 mg twice daily in preventing relapse of endoscopic recurrence of erosive esophagitis.
Simon TJ; Roberts WG; Berlin RG; Hayden LJ; Berman RS; Reagan JE
Clin Ther; 1995; 17(6):1147-56. PubMed ID: 8750406
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of famotidine in patients with acute gastric mucosal injury after continuous infusion of cisplatin plus vindesine.
Mori K; Tominaga K; Yokoyama K; Suga Y; Kishiro I; Tsurui M
J Cancer Res Clin Oncol; 1995; 121(6):367-70. PubMed ID: 7797602
[TBL] [Abstract][Full Text] [Related]
31. Fixed-dose ibuprofen/famotidine: a review of its use to reduce the risk of gastric and duodenal ulcers in patients requiring NSAID therapy.
Deeks ED
Clin Drug Investig; 2013 Sep; 33(9):689-97. PubMed ID: 23881568
[TBL] [Abstract][Full Text] [Related]
32. Ranitidine in the prevention of gastric and duodenal ulcer relapse.
Alstead EM; Ryan FP; Holdsworth CD; Ashton MG; Moore M
Gut; 1983 May; 24(5):418-20. PubMed ID: 6301956
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of gastric ulcer with sucralfate and famotidine].
Hoffenberg P; Reyes V; Palma J; Ossa P; Maggiolo P; Klinger J
Rev Med Chil; 1991 Jan; 119(1):45-9. PubMed ID: 1824143
[TBL] [Abstract][Full Text] [Related]
34. Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.
Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Uchida T; Fujiwara Y; Arakawa T
Int J Clin Pharmacol Res; 2005; 25(4):187-94. PubMed ID: 16402635
[TBL] [Abstract][Full Text] [Related]
35. Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial.
Ye BD; Cheon JH; Choi KD; Kim SG; Kim JS; Jung HC; Song IS
Aliment Pharmacol Ther; 2006 Sep; 24(5):837-43. PubMed ID: 16918888
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for delayed healing of duodenal ulcers treated with famotidine and ranitidine.
Reynolds JC; Schoen RE; Maislin G; Zangari GG
Am J Gastroenterol; 1994 Apr; 89(4):571-80. PubMed ID: 8147361
[TBL] [Abstract][Full Text] [Related]
37. Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration.
Hudson N; Taha AS; Russell RI; Trye P; Cottrell J; Mann SG; Swanell AJ; Sturrock RD; Hawkey CJ
Gastroenterology; 1997 Jun; 112(6):1817-22. PubMed ID: 9178671
[TBL] [Abstract][Full Text] [Related]
38. Comparison of roxatidine and famotidine on nocturnal gastric juice secretion.
Tanioka H; Kaga K
J Int Med Res; 1996; 24(1):88-91. PubMed ID: 8674804
[TBL] [Abstract][Full Text] [Related]
39. Cimetidine in the prevention of gastric ulcer relapse.
Machell RJ; Ciclitira PJ; Farthing MJ; Dick AP; Hunter JO
Postgrad Med J; 1979 Jun; 55(644):393-5. PubMed ID: 482183
[TBL] [Abstract][Full Text] [Related]
40. A multicenter, randomized, double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease.
McCullough AJ
Am J Med; 1986 Oct; 81(4B):17-24. PubMed ID: 2877570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
